Status:

UNKNOWN

Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic

Lead Sponsor:

Karadeniz Technical University

Conditions:

Critical Illness

Eligibility:

All Genders

28-18 years

Brief Summary

One of the most important factors in pediatric emergency units is the correct decision of the patient inpatient or outpatient treatment. If the disease progresses critically, the decision of hospital...

Detailed Description

Triage is the primary step where the first treatment service of a patient admitted to the emergency unit is initiated. The purpose of triage in the emergency room is a rapid assessment to determine t...

Eligibility Criteria

Inclusion

  • \- Pediatric patients aged between 28 days and 18 years, who applied to the Pediatric Emergency Unit

Exclusion

  • In the follow-up or at the begining, patients who are presenting with cardiorespiratory arrest
  • Intubated patients,
  • Trauma patients
  • Neonatal period (\<28 days),
  • Patients who leave the hospital at the request of their family before the end of the diagnosis or treatment process
  • Patients who do not have permission from their parents at the beginning

Key Trial Info

Start Date :

February 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 15 2021

Estimated Enrollment :

894 Patients enrolled

Trial Details

Trial ID

NCT04876872

Start Date

February 1 2021

End Date

September 15 2021

Last Update

May 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Karadeniz Technical University Faculty of Medicine Farabi Hospital

Trabzon, Turkey (Türkiye), 9061080

Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic | DecenTrialz